Inventor · disambiguated record
Junqing Guo
Also filed as: GUO JUNQING
18 granted patents·4 pending applications·77 citations·filing 2002–2024
90Inventor score
Top patents by PatentIndex Score
22 records- 0195US11767322B2Triazolopyridinyl compounds as kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2021·Granted Sep 26, 2023·3 cites·66 claims
- 0293US10913738B2Aminotriazolopyridines as kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Feb 9, 2021·7 cites·14 claims
- 0387US7087614B2Pyrimidine inhibitors of phosphodiesterase (PDE) 7BRISTOL MYERS SQUIBB CO·Filed 2002·Granted Aug 8, 2006·35 cites·7 claims
- 0486US7105667B2Fused heterocyclic compounds and use thereofBRISTOL MYERS SQUIBB CO·Filed 2002·Granted Sep 12, 2006·25 cites·6 claims
- 0580US7737279B21,6-dihydro-1,3,5,6-tetraaza-as-indacene based tricyclic compounds and pharmaceutical compositions comprising sameBRISTOL MYERS SQUIBB CO·Filed 2006·Granted Jun 15, 2010·4 cites·8 claims
- 0679US12110290B2Triazolopyridinyl compounds as kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2023·Granted Oct 8, 2024·0 cites·14 claims
- 0779US2025074909A1Aminotriazolopyridines as kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2024·Application pending·0 cites
- 0878US2024425505A1Triazolopyridinyl compounds as kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2024·Application pending·0 cites
- 0970US8987268B2Pyrrolopyridazine JAK3 inhibitors and their use for the treatment of inflammatory and autoimmune diseasesWROBLESKI STEPHEN T·Filed 2012·Granted Mar 24, 2015·2 cites·14 claims
- 1067US12157733B2Aminotriazolopyridines as kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2020·Granted Dec 3, 2024·0 cites·6 claims
- 1164US9221826B2Pyrrolopyridazine JAK3 inhibitors and their use for the treatment of inflammatory and autoimmune diseasesWROBLESKI STEPHEN T·Filed 2012·Granted Dec 29, 2015·1 cites·10 claims
- 1260US7981881B2Fused heterocyclic compounds and use thereofBRISTOL MYERS SQUIBB CO·Filed 2008·Granted Jul 19, 2011·0 cites·9 claims
- 1355US12275721B2Indazole carboxamides as kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2020·Granted Apr 15, 2025·0 cites·12 claims
- 1453US7384937B2Fused heterocyclic compounds and use thereofBRISTOL MYERS SQUIBB CO·Filed 2003·Granted Jun 10, 2008·0 cites·12 claims
- 1551US12084426B2Indazole carboxamides as kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2019·Granted Sep 10, 2024·0 cites·13 claims
- 1650US2011230468A1Fused heterocyclic compounds and uses thereofBRISTOL MYERS SQUIBB CO·Filed 2011·Application pending·0 cites
- 1748US12172975B21H-indazole carboxamides as receptor-interacting protein kinase 1 inhibitors (RIPK1)BRISTOL MYERS SQUIBB CO·Filed 2019·Granted Dec 24, 2024·0 cites·12 claims
- 1846US2003092908A1Fused heterocyclic inhibitors of phosphodiesterase (PDE) 7Filed 2002·Application pending·0 cites
- 1944US11618753B2Aminopyrrolotriazines as kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2019·Granted Apr 4, 2023·0 cites·9 claims
- 2042US8268855B21,6-dihydro-1,3,5,6-tetraaza-as-indacene based tricyclic compounds and pharmaceutical compositions comprising samePITTS WILLIAM J·Filed 2010·Granted Sep 18, 2012·0 cites·8 claims
- 2138US8921368B2Pyrrolopyridazine JAK3 inhibitors and their use for the treatment of inflammatory and autoimmune diseasesWROBLESKI STEPHEN T·Filed 2012·Granted Dec 30, 2014·0 cites·9 claims
- 2236US10301306B2Substituted dihydro-1H-pyrrolo[3,2-c]pyridin-4(5H)-ones as RIPK3 inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2015·Granted May 28, 2019·0 cites·14 claims
Join the waitlist — get patent alerts
Get an alert when Junqing Guo files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →